ORGO ORGANOGENESIS HLDGS INC revenue, earnings and financials
For the quarter ended June 30, 2026, ORGANOGENESIS HLDGS INC reported revenue of $43.8M (down 56.7% from a year earlier), net income of −$96.3M and diluted EPS of −$0.77; over the last four quarters revenue was $457M and net income −$84.2M; for the fiscal year ended December 2025 revenue was $564M, up 17.0% on the year before.
ORGO annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $564M, gross profit n/a, operating income $44.7M, net income $37.0M (margin 6.6%), EPS $0.15
- Fiscal year ended Dec 2024: revenue $482M, gross profit $366M, operating income −$1.28M, net income $900K (margin 0.2%), EPS −$0.01
- Fiscal year ended Dec 2023: revenue $433M, gross profit $327M, operating income $12.5M, net income $4.90M (margin 1.1%), EPS $0.04
- Fiscal year ended Dec 2022: revenue $451M, gross profit $346M, operating income $22.3M, net income $15.5M (margin 3.4%), EPS $0.12
- Fiscal year ended Dec 2021: revenue $467M, gross profit $353M, operating income $72.2M, net income $94.2M (margin 20.2%), EPS $0.70
ORGO quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $43.8M (down 56.7% year over year), net income −$96.3M, EPS −$0.77
- Quarter ended Mar 31, 2026: revenue $37.2M (down 57.1% year over year), net income −$53.2M, EPS −$0.44
- Quarter ended Dec 31, 2025 (from the annual report): revenue $226M (up 78.1% year over year), net income $43.7M, EPS $0.31
- Quarter ended Sep 30, 2025: revenue $151M (up 31.0% year over year), net income $21.6M, EPS $0.11
- Quarter ended Jun 30, 2025: revenue $101M (down 22.4% year over year), net income −$9.39M, EPS −$0.10
- Quarter ended Mar 31, 2025: revenue $86.7M (down 21.2% year over year), net income −$18.8M, EPS −$0.17
- Quarter ended Dec 31, 2024 (from the annual report): revenue $127M (up 27.1% year over year), net income $7.71M, EPS $0.05
- Quarter ended Sep 30, 2024: revenue $115M (up 6.1% year over year), net income $12.3M, EPS $0.09
- Quarter ended Jun 30, 2024: revenue $130M (up 11.0% year over year), net income −$17.0M, EPS −$0.13
- Quarter ended Mar 31, 2024: revenue $110M (up 2.2% year over year), net income −$2.10M, EPS −$0.02
- Quarter ended Dec 31, 2023 (from the annual report): revenue $99.7M (down 13.7% year over year), net income −$614K, EPS $0.00
- Quarter ended Sep 30, 2023: revenue $109M (down 7.1% year over year), net income $3.17M, EPS $0.02
- Quarter ended Jun 30, 2023: revenue $117M (down 3.4% year over year), net income $5.32M, EPS $0.04
- Quarter ended Mar 31, 2023: revenue $108M (up 10.8% year over year), net income −$2.97M, EPS −$0.02
- Quarter ended Dec 31, 2022 (from the annual report): revenue $116M (down 9.7% year over year), net income $7.45M, EPS $0.06
- Quarter ended Sep 30, 2022: revenue $117M (up 2.7% year over year), net income $215K, EPS $0.00
- Quarter ended Jun 30, 2022: revenue $121M (down 1.5% year over year), net income $8.74M, EPS $0.07
- Quarter ended Mar 31, 2022: revenue $97.1M (down 5.3% year over year), net income −$913K, EPS −$0.01
- Quarter ended Dec 31, 2021 (from the annual report): revenue $128M, net income $51.0M, EPS $0.39
- Quarter ended Sep 30, 2021: revenue $114M, net income $12.6M, EPS $0.09
ORGO cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$10.3M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $14.2M, share buybacks $25.5M
- Fiscal year ended Dec 2023: operating cash flow $30.9M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow $24.9M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow $62.0M, share buybacks n/a
ORGO balance sheet
- Jun 30, 2026: cash $46.1M, total assets $406M, total liabilities $118M, shareholders' equity $148M
- Mar 31, 2026: cash $91.4M, total assets $520M, total liabilities $139M, shareholders' equity $245M
- Dec 31, 2025: cash $93.7M, total assets $599M, total liabilities $165M, shareholders' equity $300M
- Sep 30, 2025: cash $63.7M, total assets $510M, total liabilities $124M, shareholders' equity $255M
- Jun 30, 2025: cash $73.1M, total assets $461M, total liabilities $99.9M, shareholders' equity $233M
- Mar 31, 2025: cash $110M, total assets $467M, total liabilities $99.3M, shareholders' equity $243M
- Dec 31, 2024: cash $136M, total assets $498M, total liabilities $113M, shareholders' equity $263M
- Sep 30, 2024: cash $94.3M, total assets $446M, total liabilities $168M, shareholders' equity $279M
What is ORGO's revenue?
ORGANOGENESIS HLDGS INC reported $457M of revenue over its last four quarters, through June 30, 2026.
Is ORGO profitable?
No. ORGANOGENESIS HLDGS INC lost $84.2M over the last four quarters.
What is ORGO's EPS?
Diluted earnings per share over the last four quarters were −$0.79; −$0.77 in the latest quarter.